Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Biochemical consequences of mechanical forces generated by distention and distortion
1989
Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation
1996
Anti‐protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation
2005
Risk factors for catheter-related thrombosis in cancer patients
2004
Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation
1997
Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin
2001
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation
1994
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Comparative Effects of Small and Large Aprotinin Doses on Bleeding During Orthotopic Liver Transplantation
1995
Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery
1998
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation
1995
The molecular basis of blood coagulation
1988 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Prevention of VTE in Nonsurgical Patients
2012 Standout
Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation
1996
Catheter-Related Thrombosis in Cancer Patients: Pathophysiology, Diagnosis, and Management
2005
Pegaspargase: a review of clinical studies
2003
Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial
2008
Modulators of coagulation. A critical appraisal of their role in sepsis
1992
Die Wirkung von Aprotinin
1997
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study
2010
Cardiovascular Risk Factors and Venous Thromboembolism Incidence
2002
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
The genetics of venous and arterial thromboembolism
2001
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Diabetes and Atherosclerosis
2002 Standout
Purpura Fulminans Due toStaphylococcus aureus
2005
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Obesity and Cardiovascular Disease
2009 Standout
Prevention of Venous Thromboembolism
2004 Standout
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study
2001
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter
2003
Prevention of Venous Thromboembolism
2008 Standout
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
2010
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis
2008
On the mechanisms of biocompatibility
2008 Standout
Disseminated Intravascular Coagulation
1999 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
2012
Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction
1990
Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside
2003
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
2003
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles.
1986
Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin
2001
Maturation of the hemostatic system during childhood
1992 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Deep vein thrombosis associated with central venous catheters – a review
2005
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
2003
Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions
2001 Standout
Atherosclerosis: Basic Mechanisms
1995 Standout
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
2000 Standout
Mechanotransduction Across the Cell Surface and Through the Cytoskeleton
1993 StandoutScience
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
2006
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antifibrinolytic drugs for acute traumatic injury
2015
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
2017
Comparison of Two Automated Coagulometers and the Manual Tilt-Tube Method for the Determination of Prothrombin Time
1989
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
2014
Hemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults
1987
The Epidemiology of Venous Thromboembolism
2003 Standout
Coronary Plaque Disruption
1995 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation
2006
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
1994
Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation
1997
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Activation of the Hemostatic Mechanism After Pharmacological Cardioversion of Acute Nonvalvular Atrial Fibrillation
1997
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
1995
Thrombotic Complications of Central Venous Catheters in Cancer Patients
2004
Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study
2000
Works of M. Barthels being referenced
Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans
1995
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters
1999
Coagulation disorder during liver transplantation
1991
Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage
2003
Influence of High-Dose Aprotinin on Hemostasis and Blood Requirement in Orthotopic Liver Transplantation
1993
The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss
1991
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study
2007
THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL
1987
Substitution of Lipids with Bile Salts in the Formation of Thrombin
1969
Multicenter Evaluation of a Chromogenic Substrate Method for Photometric Determination of Prothrombin Time
1987
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
2000
[Prevention of thromboembolism in surgery].
1988
[Effectiveness of low molecular weight heparin (Fragmin) in the prevention of thromboembolism in internal medicine patients. A randomized double-blind study].
1988
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
1991
Thromboembolic Complications in Children with Nephrotic Syndrome
1986
[Early changes of the coagulation system in multiple injuries and their modification with heparin and Trasylol].
1977
Short term extreme increases in plasminogen activator inhibitor 1 (PAI-1) in plasma of polytrauma patients
1988